The Europe Coronary stents Market would witness market growth of 7.3% CAGR during the forecast period (2018 – 2024). Unhealthy lifestyle among working class has had a huge impact on the health. Due to unhealthy lifestyle among masses, the incidences of cardiovascular conditions have significantly increased over the years. Other market driving factors which are highly prevalent among the age group of 55 and 65 such as decreased elasticity of cardiac muscles, high blood pressure, and arteries block are further driving the market. Cholesterol and blood clots are prevalent among the age group of 25 and 54 too, which further adds to the market potential. The aforementioned conditions lead to chest pain (Angina) and heart attacks. Cumulatively, all these factors have led to the demand for coronary repair solutions in Europe.
Based on Product Type, the market is segmented into Drug-eluting stents (DES), Bare-Metal Stents and Bioresorbable Vascular Scaffold. Drug-eluting stents (DES) are further classified into Polymer Based Coatings and Polymer Free Coatings. Polymer Free Coatings is segmented into Micro Structured Surface, Micro porous Surface, Slotted Tubular Surface and Nanoporous Surface. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
Scope of the Study
Market Segmentation:
By Product Type
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
